Chemical Formula: C19H25NO

Chemical Formula C19H25NO

Found 39 metabolite its formula value is C19H25NO

Levallorphan

(1R,9R,10R)-17-(prop-2-en-1-yl)-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-trien-4-ol

C19H25NO (283.1936)


An opioid antagonist with properties similar to those of naloxone; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683) D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Histrionicotoxin

(2S,6R,10S,11S)-11-[(E)-but-1-en-3-ynyl]-2-[(E)-pent-2-en-4-ynyl]-1-azaspiro[5.5]undecan-10-ol

C19H25NO (283.1936)


An azaspiro compound that is 1-azaspiro[5.5]undecane substituted by a hydroxy group at position 8, a but-1-en-3-yn-1-yl group at position 7 and a pent-3-en-1-yn-5-yl group at position 2 (the 2S,6R,7S,8S stereoisomer).

   

N-Dealkylated tolterodine

4-methyl-2-[(1R)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.1936)


N-Dealkylated tolterodine is only found in individuals that have used or taken tolterodine. N-Dealkylated tolterodine is a metabolite of tolterodine. N-Dealkylated tolterodine belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.

   

Tesmilifene

N,N-Diethyl-2-((4-phenylmethyl)phenoxy)-ethanamine hydrochloride

C19H25NO (283.1936)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

N-(ortho-methoxybenzyl)-4-ethylamphetamine

N-(ortho-methoxybenzyl)-4-ethylamphetamine

C19H25NO (283.1936)


   

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

(2E,4E,12Z)-3-Methylbutylamide-2,4,12-Tetradecatriene-8,10-diynoic aci

C19H25NO (283.1936)


   

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

tetradeca-2E,4E,6E,10E-tetraen-8-ynoic acid piperidide

C19H25NO (283.1936)


   

2,4-Tetradecadien-8,10-diynoic acid piperidide

2,4-Tetradecadien-8,10-diynoic acid piperidide

C19H25NO (283.1936)


   

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

1-methyl-2-[(Z)-4-nonenyl]-4(1H)-quinolone

C19H25NO (283.1936)


   

SCHEMBL8497246

3-methyl-2-non-2-enyl-1H-quinolin-4-one

C19H25NO (283.1936)


   

Propoxyphene carbinol

[S-(R*,S*)]-alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenylphenethyl alcohol

C19H25NO (283.1936)


   

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2S,6R,7S,8S)-7-((E)-but-1-en-3-yn-1-yl)-2-((E)-pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

N-Dealkylatedtolterodine

4-methyl-2-[(1S)-1-phenyl-3-[(propan-2-yl)amino]propyl]phenol

C19H25NO (283.1936)


   

Drobuline

Drobuline

C19H25NO (283.1936)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent

   

2-amino-1,1-diphenylheptan-1-ol

2-amino-1,1-diphenylheptan-1-ol

C19H25NO (283.1936)


   

Alentemol

Alentemol

C19H25NO (283.1936)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

1-Butanol,2-[bis(phenylmethyl)amino]-3-methyl-, (2S)-

C19H25NO (283.1936)


   

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

(2r 3s)-(-)-4-dimethylamino-1 2-dipheny&

C19H25NO (283.1936)


   

levallorphan hydrogen tartrate

levallorphan hydrogen tartrate

C19H25NO (283.1936)


   

Sdccgsbi-0050749.P002

Sdccgsbi-0050749.P002

C19H25NO (283.1936)


   

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

4-[3-[Methyl(2-phenylethyl)amino]butyl]phenol

C19H25NO (283.1936)


   

levallorphan

levallorphan

C19H25NO (283.1936)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Tesmilifene

Tesmilifene

C19H25NO (283.1936)


C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist

   

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

4-methyl-2-[(1R)-1-phenyl-3-(propan-2-ylamino)propyl]phenol

C19H25NO (283.1936)


   

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

Benzeneethanol, alpha-[2-(dimethylamino)-1-methylethyl]-alpha-phenyl-

C19H25NO (283.1936)


   

(2r,6s,7s,8r)-7-[(1e)-but-1-en-3-yn-1-yl]-2-[(2e)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2r,6s,7s,8r)-7-[(1e)-but-1-en-3-yn-1-yl]-2-[(2e)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

(2e,4e,6e,10e)-1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

(2e,4e,6e,10e)-1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

C19H25NO (283.1936)


   

(2s,6r,7s,8r)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8r)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

3-methyl-2-(non-2-en-1-yl)-1h-quinolin-4-one

3-methyl-2-(non-2-en-1-yl)-1h-quinolin-4-one

C19H25NO (283.1936)


   

(2e,4e,12z)-n-(3-methylbutyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

(2e,4e,12z)-n-(3-methylbutyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

C19H25NO (283.1936)


   

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

(2s,6r,7s,8s)-7-[(1z)-but-1-en-3-yn-1-yl]-2-[(2z)-pent-2-en-4-yn-1-yl]-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

1-(piperidin-1-yl)tetradeca-2,4,6,10-tetraen-8-yn-1-one

C19H25NO (283.1936)


   

3-methyl-2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

3-methyl-2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

C19H25NO (283.1936)


   

7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-indeno[2,1-b]pyridin-7-one

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-indeno[2,1-b]pyridin-7-one

C19H25NO (283.1936)


   

(2r,6s,7s,8r)-7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

(2r,6s,7s,8r)-7-(but-1-en-3-yn-1-yl)-2-(pent-2-en-4-yn-1-yl)-1-azaspiro[5.5]undecan-8-ol

C19H25NO (283.1936)


   

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-cyclopenta[g]quinolin-7-one

(8as)-6-isopropyl-2,2,4,8a-tetramethyl-8h,9h-cyclopenta[g]quinolin-7-one

C19H25NO (283.1936)


   

n-[(3e,5e)-6,8-dimethyldeca-3,5,9-trien-2-yl]benzenecarboximidic acid

n-[(3e,5e)-6,8-dimethyldeca-3,5,9-trien-2-yl]benzenecarboximidic acid

C19H25NO (283.1936)


   

2-(2-Nonenyl)-3-methylquinolin-4(1H)-one

3-methyl-2-[(E)-non-2-enyl]-1H-quinolin-4-one

C19H25NO (283.1936)


2-(2-nonenyl)-3-methyl-4-quinolonone is a member of quinolines. 2-(2-Nonenyl)-3-methylquinolin-4(1H)-one has been reported in Burkholderia cepacia with data available.